LEGISLATIVE SERVICES AGENCY
OFFICE OF FISCAL AND MANAGEMENT ANALYSIS
200 W. Washington St., Suite 301
Indianapolis, IN 46204
(317) 233-0696
iga.in.gov
FISCAL IMPACT STATEMENT
LS 6718 NOTE PREPARED: Dec 29, 2023
BILL NUMBER: SB 168 BILL AMENDED:
SUBJECT: 340B Drug Program Report.
FIRST AUTHOR: Sen. Charbonneau BILL STATUS: As Introduced
FIRST SPONSOR:
FUNDS AFFECTED:XGENERAL IMPACT: State
XDEDICATED
FEDERAL
Summary of Legislation: The bill requires an entity authorized to participate in the federal 340B Drug
Pricing Program to annually report specified data to the Indiana Department of Health (IDOH). It requires
the IDOH to submit a report of the aggregated data to the Legislative Council and post the report on the
IDOH's website.
Effective Date: July 1, 2024.
Explanation of State Expenditures: Requirements of the bill represent an increase in workload for the
Indiana Department of Health (IDOH). Total impact on workload will depend on the extent to which the
IDOH is able to utilize existing resources and tools, such as the State Health Gateway, and ensure complete
reporting of data from required entities. [IDOH’s administrative expenses are paid from the Tobacco Master
Settlement Fund, a dedicated fund.]
Additional Information - The IDOH has 140 vacant positions as of December 2023.
Explanation of State Revenues:
Explanation of Local Expenditures:
Explanation of Local Revenues:
State Agencies Affected: Indiana Department of Health.
SB 168 1 Local Agencies Affected:
Information Sources: State Staffing Data, December 2023.
Fiscal Analyst: Karen Rossen, 317-234-2106.
SB 168 2